Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

IRMD

IRADIMED CORP

Healthcare · Surgical & Medical Instruments & Apparatus

$86.66Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

IRADIMED CORP shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +0% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +0% YoY in Q2 FY2026

Pipeline evidence · 22d ago

IRMD's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on IRMD.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full IRMD earnings analysis

Reported figures for IRADIMED CORP — research only, not investment advice.

Revenue YoY
+0.3%
EPS YoY
-8.9%

Latest Intelligence

Updated

What happened recently for IRADIMED CORP (IRMD) — events, not interpretation.

Event
Reported Q2 2026 revenue +0% YoY.
Also
Last session September 28, 2026 at $86.66.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

IRADIMED CORP (IRMD)

Healthcare · Surgical & Medical Instruments & Apparatus

Investment Snapshot above is the primary AlphaOS analysis for IRADIMED CORP — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$1.11B
Revenue:
$20.47M

IRMD earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow IRADIMED CORP through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.